Navigation Links
China Sky One Medical Receives Medical Industry Awards
Date:1/27/2011

HARBIN, China, Jan. 27, 2011 /PRNewswire-Asia/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong"), the Company's wholly owned operating subsidiary, was named a "Top Ten Branded Company Trusted by Consumers" according to research and rankings conducted jointly by influential and authoritative institutions including, China Medical Association, China Pharmaceutical Association, China Medical Brand Research Association, and the Brand Research Center of Business Times Newspaper. The designation is based on product quality and brand recognition among domestic Chinese pharmaceutical companies. Additionally, China Sky One's "Yu Fu" branded Compound Camphor Cream was named a "Top Ten Brand for Skin Treatment Medicine" and Mr. Yan-qing Liu, the Company's Chairman and CEO, was elected as a "Top Ten Trusted Entrepreneur in China's Medical Industry." Please click here to view certificates of these awards.

(Photo:  http://photos.prnewswire.com/prnh/20110127/CN37464 )

"We are honored to receive these awards and appreciate the ongoing support of our loyal customers. Entering 2011, we will strive to maintain the highest product quality standards and introduce more innovative new products to address the needs of China's large and growing health care market," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical.

About China Sky One Medical, Inc. China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company, Harbin First Bio-Engineering Company Limited, Heilongjiang Tianlong Pharmaceutical, Inc. and Peng Lai Jin Chuang Pharmaceutical Company, the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn.

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the Company's brand recognition and product quality. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.Investor Relations Contact:China Sky One Medical

CCG Investor RelationsYanqing Liu, CEO

Crocker Coulson, PresidentEmail: ir@cski.com.cn

Tel: +1-646-213-1915Email: crocker.coulson@ccgir.comWebsite: www.ccgirasia.com Mabel Zhang, Vice PresidentTel: +1-310-954-1353Email: mabel.zhang@ccgir.com
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent
2. Reportlinker Adds The Top 10 CMOs in China
3. Shareholder Letter from Chairman of China Sky One Medical
4. Wolters Kluwer Health Enters Joint Venture with China Drug Information Provider Medicom
5. Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry
6. Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China
7. Topical China Industries Research Reports Published at MarketPublishers.com
8. China Botanic Announces Progress on its SOX 404 Compliance Program
9. China Botanic Appoints David Dong as New Chief Financial Officer
10. Food and Drug Law Institute to Hold Historic Conference on U.S.-China Food and Drug Law
11. China Botanic Achieves Three Million RMB Sales of New Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017 ... clinical-stage oncology drug development company, announces that it ... Drug Administration (FDA) authorizing the initiation a Phase ... treatment for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) ... (RIT). MabVax plans to initiate the phase I ...
(Date:2/23/2017)... VANCOUVER, British Columbia , Feb. 23, ... ) today announced its year end 2016 financial results.  ... January 2017, OncoGenex, and Achieve Life Science, Inc., a privately ... into a definitive merger agreement under which OncoGenex will ... the proposed merger, Achieve,s stockholders are expected to own ...
(Date:2/23/2017)... 2017 This report analyzes analyzes the worldwide markets for ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year ... analytics are derived from primary and secondary research. Company profiles ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, ... symposium on “Doping in Sport: How the Culture Might Change,” in ... LLP. The symposium will be held at Pepperdine University in Malibu, California. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... and community for those in the fight against cancer, has produced a seminal ... success. HRA will release top-line findings in a webinar, Defining Compassionate Care ...
(Date:2/23/2017)... RYE, New York (PRWEB) , ... February 23, 2017 , ... ... to evaluate the safety and efficacy of CM-AT in children aged 3-8 with Autism, ... the 30 clinical sites already enrolling children across the United States. , “There ...
(Date:2/22/2017)... ... February 22, 2017 , ... Our high-octane ... overwork even the sharpest brain. , Power On, a mental performance enhancer from ... clocking the brain. Each capsule contains Cognizin® Citicoline, a branded form of the ...
(Date:2/22/2017)... ... ... The National Academy of Certified Care Managers (NACCM) has ... period. NACCM, a nonprofit organization, has provided the premier certification for Care Managers ... to ensure that newly certified professionals are prepared to work effectively on behalf ...
Breaking Medicine News(10 mins):